ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT

This adverse event was reported 1 times

These drugs are most commonly taken by patients reporting ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT:

# Drug Count
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL 1
See all common drugs associated with ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT

ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTIHEMOPHILIC FACTOR (RECOMBINANT) PEGYLATED-AUCL 1 0.0011
1 ANTIHEMOPHILIC FACTOR (RECOMBINANT) 1 0.0001
See all drugs enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT

These drug classes are most commonly taken by patients reporting ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT:

# Drug class Count
See all common drug classes associated with ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT

ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with ANTI-POLYETHYLENE GLYCOL ANTIBODY ABSENT